Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab.

Bloom BC, Augustyn A, Pezzi TA, Menon H, Mayo LL, Shah SJ, Schwartz DL, Chmura SJ, Johnson FM, Welsh JW, Chun SG.

Front Oncol. 2019 Apr 5;9:223. doi: 10.3389/fonc.2019.00223. eCollection 2019.

2.

Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.

Wang Y, Yu X, Zhao N, Wang J, Lin C, Izaguirre EW, Farmer M, Tian G, Somer B, Dubal N, Schwartz DL, Ballo MT, VanderWalde NA.

J Natl Compr Canc Netw. 2019 Jan;17(1):29-37. doi: 10.6004/jnccn.2018.7085.

PMID:
30659127
3.

Multisite reliability and repeatability of an advanced brain MRI protocol.

Schwartz DL, Tagge I, Powers K, Ahn S, Bakshi R, Calabresi PA, Todd Constable R, Grinstead J, Henry RG, Nair G, Papinutto N, Pelletier D, Shinohara R, Oh J, Reich DS, Sicotte NL, Rooney WD; NAIMS Cooperative.

J Magn Reson Imaging. 2019 Jan 16. doi: 10.1002/jmri.26652. [Epub ahead of print]

PMID:
30652391
4.

A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.

Kohno M, Dennis LE, McCready H, Schwartz DL, Hoffman WF, Korthuis PT.

Drug Alcohol Depend. 2018 Nov 1;192:186-192. doi: 10.1016/j.drugalcdep.2018.07.045. Epub 2018 Sep 21.

5.

Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer-Reply.

Chun SG, Pezzi TA, Schwartz DL.

JAMA Oncol. 2018 Oct 1;4(10):1436-1437. doi: 10.1001/jamaoncol.2018.3292. No abstract available.

PMID:
30073269
6.

Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer.

Wang Y, Farmer M, Izaguirre EW, Schwartz DL, Somer B, Tillmanns T, Ballo MT.

JAMA Oncol. 2018 Sep 1;4(9):1288-1291. doi: 10.1001/jamaoncol.2018.2677. No abstract available.

PMID:
30054609
7.

Quality of prostate cancer screening information on the websites of nationally recognized cancer centers and health organizations.

Manole BA, Wakefield DV, Dove AP, Dulaney CR, Marcrom SR, Schwartz DL, Farmer MR.

Pract Radiat Oncol. 2018 Jul - Aug;8(4):275-278. doi: 10.1016/j.prro.2017.12.010. Epub 2017 Dec 24.

PMID:
29452874
8.

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.

Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG.

JAMA Oncol. 2018 Aug 1;4(8):e174504. doi: 10.1001/jamaoncol.2017.4504. Epub 2018 Aug 9.

9.

Minimal mask immobilization with optical surface guidance for head and neck radiotherapy.

Zhao B, Maquilan G, Jiang S, Schwartz DL.

J Appl Clin Med Phys. 2018 Jan;19(1):17-24. doi: 10.1002/acm2.12211. Epub 2017 Nov 9.

10.

MR Imaging-based Multimodal Autoidentification of Perivascular Spaces (mMAPS): Automated Morphologic Segmentation of Enlarged Perivascular Spaces at Clinical Field Strength.

Boespflug EL, Schwartz DL, Lahna D, Pollock J, Iliff JJ, Kaye JA, Rooney W, Silbert LC.

Radiology. 2018 Feb;286(2):632-642. doi: 10.1148/radiol.2017170205. Epub 2017 Aug 29.

11.

mHealth: Mobile Technologies to Virtually Bring the Patient Into an Oncology Practice.

Pennell NA, Dicker AP, Tran C, Jim HSL, Schwartz DL, Stepanski EJ.

Am Soc Clin Oncol Educ Book. 2017;37:144-154. doi: 10.14694/EDBK_176093.

12.

The Grapefruit: An Alternative Arthroscopic Tool Skill Platform.

Molho DA, Sylvia SM, Schwartz DL, Merwin SL, Levy IM.

Arthroscopy. 2017 Aug;33(8):1567-1572. doi: 10.1016/j.arthro.2017.03.010. Epub 2017 May 11.

PMID:
28502388
13.

Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.

Ding C, Chun SG, Sumer BD, Nedzi LA, Abdulrahman RE, Yordy JS, Lee P, Hrycushko B, Solberg TD, Ahn C, Timmerman RD, Schwartz DL.

Med Dosim. 2017 Summer;42(2):90-96. doi: 10.1016/j.meddos.2017.01.004. Epub 2017 Apr 21.

PMID:
28438431
14.

Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning.

Mao W, Rozario T, Lu W, Gu X, Yan Y, Jia X, Sumer B, Schwartz DL.

J Appl Clin Med Phys. 2017 Jan;18(1):157-163. doi: 10.1002/acm2.12019. Epub 2016 Dec 22.

15.

Interruptions of Head and Neck Radiotherapy Across Insured and Indigent Patient Populations.

Thomas K, Martin T, Gao A, Ahn C, Wilhelm H, Schwartz DL.

J Oncol Pract. 2017 Apr;13(4):e319-e328. doi: 10.1200/JOP.2016.017863. Epub 2017 Mar 7. Erratum in: J Oncol Pract. 2017 Jul;13(7):466.

PMID:
28267393
16.

Improving patient health engagement with mobile texting: A pilot study in the head and neck postoperative setting.

Sosa A, Heineman N, Thomas K, Tang K, Feinstein M, Martin MY, Sumer B, Schwartz DL.

Head Neck. 2017 May;39(5):988-995. doi: 10.1002/hed.24718. Epub 2017 Mar 6.

17.

SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial.

Schwartz DL, Sosa A, Chun SG, Ding C, Xie XJ, Nedzi LA, Timmerman RD, Sumer BD.

PLoS One. 2017 Mar 2;12(3):e0172055. doi: 10.1371/journal.pone.0172055. eCollection 2017.

18.

Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.

Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai SY, Gross ND, Schwartz DL, Hutcheson KA.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):700-708. doi: 10.1016/j.ijrobp.2016.06.010. Epub 2016 Jun 15.

19.

Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.

Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA.

Laryngoscope. 2017 Apr;127(4):842-848. doi: 10.1002/lary.26153. Epub 2016 Jul 21.

20.

Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.

McConnell HL, Schwartz DL, Richardson BE, Woltjer RL, Muldoon LL, Neuwelt EA.

Nanomedicine. 2016 Aug;12(6):1535-42. doi: 10.1016/j.nano.2016.03.009. Epub 2016 Apr 9.

21.

Quercetin as an Augmentation Agent in Schizophrenia.

Schwartz DL.

J Clin Psychopharmacol. 2016 Jun;36(3):282-3. doi: 10.1097/JCP.0000000000000498. No abstract available.

PMID:
27035495
22.

Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis.

Sher DJ, Schwartz DL, Nedzi L, Khan S, Hughes R, Fidler MJ, Koshy M.

Oral Oncol. 2016 Mar;54:58-67. doi: 10.1016/j.oraloncology.2015.12.008. Epub 2016 Jan 18.

PMID:
26794877
23.

Preparation for future learning: a missing competency in health professions education?

Mylopoulos M, Brydges R, Woods NN, Manzone J, Schwartz DL.

Med Educ. 2016 Jan;50(1):115-23. doi: 10.1111/medu.12893.

PMID:
26695471
24.

A multimodality segmentation framework for automatic target delineation in head and neck radiotherapy.

Yang J, Beadle BM, Garden AS, Schwartz DL, Aristophanous M.

Med Phys. 2015 Sep;42(9):5310-20. doi: 10.1118/1.4928485.

25.

Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers.

Chun SG, Park H, Pandita RK, Horikoshi N, Pandita TK, Schwartz DL, Yordy JS.

Am J Cancer Res. 2015 Mar 15;5(4):1337-52. eCollection 2015.

26.
27.

Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.

Schwartz DL, Harris J, Yao M, Rosenthal DI, Opanowski A, Levering A, Ang KK, Trotti AM, Garden AS, Jones CU, Harari P, Foote R, Holland J, Zhang Q, Le QT.

Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):721-9. doi: 10.1016/j.ijrobp.2014.12.023.

28.

Energy drinks and youth self-reported hyperactivity/inattention symptoms.

Schwartz DL, Gilstad-Hayden K, Carroll-Scott A, Grilo SA, McCaslin C, Schwartz M, Ickovics JR.

Acad Pediatr. 2015 May-Jun;15(3):297-304. doi: 10.1016/j.acap.2014.11.006. Epub 2015 Feb 9.

29.

Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison.

Awan MJ, Mohamed AS, Lewin JS, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Fuller CD, Hutcheson KA.

Oral Oncol. 2014 Aug;50(8):746-52. doi: 10.1016/j.oraloncology.2014.05.003. Epub 2014 Jun 3.

30.

Give your ideas some legs: the positive effect of walking on creative thinking.

Oppezzo M, Schwartz DL.

J Exp Psychol Learn Mem Cogn. 2014 Jul;40(4):1142-52. doi: 10.1037/a0036577. Epub 2014 Apr 21.

PMID:
24749966
31.

Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial.

Schwartz DL, Garden AS, Shah SJ, Chronowski G, Sejpal S, Rosenthal DI, Chen Y, Zhang Y, Zhang L, Wong PF, Garcia JA, Kian Ang K, Dong L.

Radiother Oncol. 2013 Jan;106(1):80-4. doi: 10.1016/j.radonc.2012.10.010. Epub 2013 Jan 29.

PMID:
23369744
32.

Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy.

Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, Beadle BM, Gunn GB, Schwartz DL, Kies MS, Weber RS, Ang KK, Rosenthal DI.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):941-7. doi: 10.1016/j.ijrobp.2012.08.004. Epub 2012 Sep 11.

PMID:
22975604
33.

Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.

Riegel AC, Antone J, Schwartz DL.

Med Dosim. 2013 Spring;38(1):66-9. doi: 10.1016/j.meddos.2012.07.002. Epub 2012 Aug 15.

PMID:
22901745
34.

Impact of HPV-related head and neck cancer in clinical trials: opportunity to translate scientific insight into personalized care.

Chung CH, Schwartz DL.

Otolaryngol Clin North Am. 2012 Aug;45(4):795-806. doi: 10.1016/j.otc.2012.04.002. Epub 2012 May 30. Review.

PMID:
22793853
35.

Metabolic imaging biomarkers of postradiotherapy xerostomia.

Cannon B, Schwartz DL, Dong L.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1609-16. doi: 10.1016/j.ijrobp.2011.10.074. Epub 2012 May 30.

36.

Beyond natural numbers: negative number representation in parietal cortex.

Blair KP, Rosenberg-Lee M, Tsang JM, Schwartz DL, Menon V.

Front Hum Neurosci. 2012 Feb 10;6:7. doi: 10.3389/fnhum.2012.00007. eCollection 2012.

37.

Current progress in adaptive radiation therapy for head and neck cancer.

Schwartz DL.

Curr Oncol Rep. 2012 Apr;14(2):139-47. doi: 10.1007/s11912-012-0221-4. Review.

PMID:
22328127
38.

Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Lucs A, Saltman B, Chung CH, Steinberg BM, Schwartz DL.

Head Neck. 2013 Feb;35(2):294-306. doi: 10.1002/hed.21975. Epub 2012 Jan 27. Review.

39.

Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.

Schwartz DL, Garden AS, Thomas J, Chen Y, Zhang Y, Lewin J, Chambers MS, Dong L.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):986-93. doi: 10.1016/j.ijrobp.2011.08.017. Epub 2011 Dec 2.

40.

Unilateral radiotherapy for the treatment of tonsil cancer.

Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Gunn GB, Kupferman ME, Ang KK, Rosenthal DI.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):204-9. doi: 10.1016/j.ijrobp.2011.06.1975. Epub 2011 Oct 20.

PMID:
22019242
41.

The mental representation of integers: an abstract-to-concrete shift in the understanding of mathematical concepts.

Varma S, Schwartz DL.

Cognition. 2011 Dec;121(3):363-85. doi: 10.1016/j.cognition.2011.08.005. Epub 2011 Sep 21.

PMID:
21939966
42.

HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance.

Schwartz DL, Bankson J, Bidaut L, He Y, Williams R, Lemos R, Thitai AK, Oh J, Volgin A, Soghomonyan S, Yeh HH, Nishii R, Mukhopadhay U, Alauddin M, Mushkudiani I, Kuno N, Krishnan S, Bornman W, Lai SY, Powis G, Hazle J, Gelovani J.

Mol Cancer Res. 2011 Mar;9(3):259-70. doi: 10.1158/1541-7786.MCR-10-0469. Epub 2011 Mar 1.

43.

DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.

Moeller BJ, Yordy JS, Williams MD, Giri U, Raju U, Molkentine DP, Byers LA, Heymach JV, Story MD, Lee JJ, Sturgis EM, Weber RS, Garden AS, Ang KK, Schwartz DL.

Clin Cancer Res. 2011 Apr 1;17(7):2035-43. doi: 10.1158/1078-0432.CCR-10-2641. Epub 2011 Feb 24.

44.

Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model.

Gule MK, Chen Y, Sano D, Frederick MJ, Zhou G, Zhao M, Milas ZL, Galer CE, Henderson YC, Jasser SA, Schwartz DL, Bankson JA, Myers JN, Lai SY.

Clin Cancer Res. 2011 Apr 15;17(8):2281-91. doi: 10.1158/1078-0432.CCR-10-2762. Epub 2011 Jan 10.

45.

Adaptive radiation therapy for head and neck cancer-can an old goal evolve into a new standard?

Schwartz DL, Dong L.

J Oncol. 2011;2011. pii: 690595. doi: 10.1155/2011/690595. Epub 2010 Aug 18.

46.

Decreasing the effective radiation dose in pediatric craniofacial CT by changing head position.

Didier RA, Kuang AA, Schwartz DL, Selden NR, Stevens DM, Bardo DM.

Pediatr Radiol. 2010 Dec;40(12):1910-7. doi: 10.1007/s00247-010-1788-2. Epub 2010 Aug 5.

PMID:
20686761
47.

Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.

Schwartz DL, Hutcheson K, Barringer D, Tucker SL, Kies M, Holsinger FC, Ang KK, Morrison WH, Rosenthal DI, Garden AS, Dong L, Lewin JS.

Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1356-65. doi: 10.1016/j.ijrobp.2009.10.002. Epub 2010 Jun 18.

48.

Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.

Schwartz DL, Bankson JA, Lemos R Jr, Lai SY, Thittai AK, He Y, Hostetter G, Demeure MJ, Von Hoff DD, Powis G.

Mol Cancer Ther. 2010 Jul;9(7):2057-67. doi: 10.1158/1535-7163.MCT-09-0768. Epub 2010 Jun 29.

49.

DNATwist: a Web-based tool for teaching middle and high school students about pharmacogenomics.

Berlin DS, Person MG, Mittal A, Oppezzo MA, Chin DB, Starr B, Klein TE, Schwartz DL, Altman RB.

Clin Pharmacol Ther. 2010 Apr;87(4):393-5. doi: 10.1038/clpt.2009.303.

50.

Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.

Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS, Glisson BS, Chao KS, Schwartz DL, Chronowski GM, El-Naggar AK, Garden AS.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1005-10. doi: 10.1016/j.ijrobp.2009.09.006. Epub 2010 Mar 6.

PMID:
20207504

Supplemental Content

Loading ...
Support Center